| DIRECT COMPETITOR COMPARISON | |
| HLF | AVP | NUS | USNA | Industry | | Market Cap: | 2.55B | 14.65B | 1.65B | 487.77M | 93.02M | | Employees: | 4,000 | 42,000 | 9,185 | 948 | 280 | | Qtrly Rev Growth (yoy): | -0.30% | -3.50% | 7.70% | 3.30% | 9.60% | | Revenue (ttm): | 2.21B | 10.01B | 1.27B | 431.21M | 71.35M | | Gross Margin (ttm): | 46.62% | 62.50% | 81.53% | 79.25% | 52.09% | | EBITDA (ttm): | 338.70M | 1.30B | 175.03M | 57.19M | 220.78K | | Oper Margins (ttm): | 12.65% | 11.26% | 11.50% | 11.61% | 7.24% | | Net Income (ttm): | 181.35M | 590.00M | 74.02M | 27.84M | N/A | | EPS (ttm): | 2.862 | 1.376 | 1.160 | 1.800 | N/A | | P/E (ttm): | 14.65 | 24.93 | 22.74 | 17.71 | 15.93 | | PEG (5 yr expected): | 0.99 | 1.87 | 1.29 | 0.94 | 0.97 | | P/S (ttm): | 1.17 | 1.48 | 1.32 | 1.09 | 1.17 |
|
| AVP = Avon Products Inc. | | NUS = Nu Skin Enterprises Inc. | | USNA = USANA Health Sciences Inc. | | Industry = Drug Related Products | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.42 | -0.14% | 57.10B | 12.31 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.16 | 0.51% | 13.64B | 15.78 | | Genzyme Corp. | GENZ | 50.95 | -0.23% | 13.52B | 29.05 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.1328 | -0.92% | 41.52B | 17.84 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.47 | -0.96% | 8.82B | 1009.59 | | Teva Pharmaceutical Industries Limited | TEVA | 52.74 | -0.26% | 46.46B | 48.25 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.28 | 0.87% | 3.96B | 19.22 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.84 | -0.92% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.88 | -0.72% | 5.46B | 109.69 | | Pfizer Inc. | PFE | 18.29 | 0.22% | 147.59B | 15.19 | | Johnson & Johnson | JNJ | 62.62 | -0.43% | 172.77B | 13.68 | | GlaxoSmithKline plc | GSK | 41.291 | -2.29% | 104.67B | 13.11 | | Sanofi-Aventis | SNY | 37.8177 | -1.59% | 98.75B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.41 | 0.05% | 125.85B | 16.59 | | RHHBY.PK | 40.80 | -1.59% | N/A | N/A | | AstraZeneca plc | AZN | 44.63 | -1.46% | 64.71B | 8.96 | | Abbott Laboratories | ABT | 54.29 | 0.39% | 83.97B | 14.71 | | Bristol-Myers Squibb Co. | BMY | 25.3895 | 0.04% | 50.30B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | AVP | | '10 Feels Pretty, Oh So Pretty
Fri, Nov 27 -
Investor's Business Daily | | • | NUS | | A Relative Price Strength Screen for All Markets
Wed, Nov 25 -
Zacks.com | | • | AVP | | Amazon: Analysts' Upgrades, Downgrades
Mon, Nov 23 -
at TheStreet.com | | • | USNA | | Investors Find Fat Gains in Nutrition Stocks
Tue, Nov 17 -
Indie Research | | • | AVP | | Why Consumers Still Spend on Beauty
Tue, Nov 17 -
at Minyanville.com | | • | NUS | | UPDATE - Nu Skin raises Q4 outlook
Tue, Nov 17 -
at Reuters | | • | NUS | | Nu Skin raises 4Q and 2009 profit and sales views
Tue, Nov 17 -
AP | | • | AVP | | [video] Options Plays on Colgate-Palmolive Co.: Mad About Options
Tue, Nov 17 -
at TheStreet.com | | • | NUS | | Nu Skin Increases Fourth Quarter and 2009 Guidance, Offers 2010 Guidance
Tue, Nov 17 -
PR Newswire | | • | NUS | | Nu Skin Enterprises to Hold 2009 Investor Day
Mon, Nov 16 -
PR Newswire | | • | AVP | | Avon Products (AVP): Zacks Rank Buy
Mon, Nov 16 -
Zacks.com | | • | USNA | | USANA HEALTH SCIENCES INC Financials
Sat, Nov 14 -
EDGAR Online Financials | | • | AVP | | [video] Value Investor Follows Buffett's Money [4.5 min]
Fri, Nov 13 -
at MarketWatch | | • | USNA | | USANA HEALTH SCIENCES INC Files SEC form 10-Q, Quarterly Report
Tue, Nov 10 -
EDGAR Online | | • | USNA | | USANA Health Sciences Launches Vitamin D Supplement
Mon, Nov 2 -
Business Wire | | • | USNA | | CEO Interview: Mannatech, Inc. - Wayne L. Badovinus
Mon, Nov 2 -
Wall Street Transcript | | | All Headlines for these symbols... |
|
|
|
0.28% Nasdaq 
Competitors
